Related Experiment Video
Updated: Jul 20, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
Effect of treatment on rectal and sigmoid motility in chronically constipated children
Insights
Chronic constipation in children is linked to reduced rectal and sigmoid motility. Treatment improved motility, but symptoms persisted, suggesting impaction, not motility, is the primary issue.
Area of Science:
- Pediatric Gastroenterology
- Colorectal Motility Studies
Background:
- Chronic constipation is a common pediatric issue.
- Rectal and sigmoid motility abnormalities may play a role in constipation.
Purpose of the Study:
- To investigate rectal and sigmoid motility in constipated children.
- To assess the impact of treatment on motility and long-term outcomes.
Main Methods:
- Utilized three pressure transducers to record motility in the lower/upper rectum and sigmoid.
- Compared motility parameters (frequency, duration, amplitude, activity, surface area) between 18 healthy and 18 constipated children.
- Monitored motility changes after 2 months of treatment and at 7-12 months and 3 years post-treatment.
Main Results:
- Constipated children exhibited significantly lower percent activity and surface area in all recording areas compared to controls (P < .05).
- Treatment with milk of magnesia significantly increased motility in constipated children (P < .05), normalizing values compared to controls (P > .1).
- Motility remained normal at 7-12 months and 3 years, though most children still experienced constipation and fecal soiling.
Conclusions:
- Hypomotility in untreated constipated children appears secondary to chronic fecal impaction and rectal distension.
- While not the primary cause, this hypomotility may contribute to constipation severity.
- Normalizing motility through treatment does not guarantee complete symptom resolution, indicating other factors are involved.
Abstract:
Using three pressure transducers, motility of the lower and upper rectum and sigmoid was recorded in 18 healthy and 18 chronically constipated children. The 36 children had a wide range of values for frequency of contractions, duration, amplitude, percent of activity, and surface area under the contraction curves. The mean values for percent of activity and surface area were significantly lower in the constipated than in the control children in all three recording areas (P less than .05). Motility in the constipated children, after 2 months of treatment that included milk of magnesia, showed significant increase when compared with corresponding pretreatment values (P less than .05), and were not different from corresponding values of the control children (P greater than .1). Seven to 12 months and 3 years later, rectal and sigmoid motility remained normal. Three-year follow-up revealed that most of the constipated children were not completely free of constipation and fecal soiling in spite of normal motility. Therefore, it appears that the hypomotility in the untreated patients was the result of the chronic fecal impaction and rectal distension and while it was not the cause of the constipation, it may have contributed to its severity.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS

